Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?

[1]  J. Bijlsma,et al.  2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases , 2022, Annals of the Rheumatic Diseases.

[2]  A. Akdoğan,et al.  QuantiFERON®-TB Gold In-Tube test can be used for screening latent tuberculosis before biological treatment in a Bacille Calmette-Guérin (BCG)-vaccinated country: the HUR-BIO single-center real-life results , 2020, Clinical Rheumatology.

[3]  Sang-Nae Cho,et al.  Comparison of QFT-Plus and QFT-GIT tests for diagnosis of M. tuberculosis infection in immunocompetent Korean subjects. , 2019, Journal of thoracic disease.

[4]  R. Belknap,et al.  Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection , 2019, Journal of Clinical Microbiology.

[5]  N. Allen,et al.  Characterization of specific CD4 and CD8 T-cell responses in QuantiFERON TB Gold-Plus TB1 and TB2 tubes. , 2018, Tuberculosis.

[6]  S. Ishikawa,et al.  Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis. , 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[7]  K. Hyrich,et al.  Biologics registers in RA: methodological aspects, current role and future applications , 2017, Nature Reviews Rheumatology.

[8]  P. Rancoita,et al.  First evaluation of QuantiFERON-TB Gold Plus performance in contact screening , 2016, European Respiratory Journal.

[9]  H. Park,et al.  QuantiFERON-TB Gold In-Tube Assay for Screening Arthritis Patients for Latent Tuberculosis Infection before Starting Anti-Tumor Necrosis Factor Treatment , 2015, PloS one.

[10]  H. Kulah,et al.  A Fully Microfabricated Electrochemical Sensor and its Implementation for Detection of Methicillin Resistance in Staphylococcus Aureus , 2014, IEEE Sensors Journal.

[11]  P. Ravn,et al.  Prednisolone treatment affects the performance of the QuantiFERON gold in‐tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection , 2011, Inflammatory bowel diseases.

[12]  K. Marten,et al.  Comparison of two interferon-γ release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases , 2010, Annals of the rheumatic diseases.

[13]  T. McDonnell,et al.  Comparison of interferon γ release assays and conventional screening tests before tumour necrosis factor α blockade in patients with inflammatory arthritis , 2009, Annals of the rheumatic diseases.

[14]  E. Acevedo-Vásquez,et al.  Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. , 2008, The Journal of rheumatology.

[15]  U. Müller-Ladner,et al.  Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay. , 2007, Rheumatology.

[16]  P. Villiger,et al.  Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon γ assay , 2007, Annals of the rheumatic diseases.

[17]  M. Pai,et al.  False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  P. Ravn,et al.  Latent Tuberculosis in HIV positive, diagnosed by the M. Tuberculosis Specific Interferon-γ test , 2006, Respiratory research.

[19]  J. Gómez-Reino,et al.  Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. , 2005, Arthritis and rheumatism.

[20]  P. Clements,et al.  Human lymphocyte subpopulations. Effect of corticosteroids. , 1974, The Journal of clinical investigation.

[21]  H. Bax,et al.  A multicentre verification study of the QuantiFERON®-TB Gold Plus assay. , 2018, Tuberculosis.

[22]  U. Wu.  Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: Performance of a Mycobacterium tuberculosis antigen-specific interferon γ assay , 2009 .

[23]  Jeffrey N. Martin,et al.  Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. , 2007, American journal of respiratory and critical care medicine.